{"name": "Algiax Pharmaceuticals",
 "permalink": "algiax-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/algiax-pharmaceuticals",
 "homepage_url": "http://www.algiax.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "+49 (0) 211 617 851 0",
 "description": "",
 "created_at": "Thu May 17 02:31:37 UTC 2012",
 "updated_at": "Thu May 17 02:31:37 UTC 2012",
 "overview": "\u003Cp\u003EAlgiax Pharmaceuticals GmbH is an independent biotechnology company that was established in April 2011. It is dedicated to the discovery and development of innovative products in the field of nervous system disease or dysfunction with a strong focus on neuropathic pain. The company is financially stable having raised 4,3 million Euro\u2019s in Series A financing from a consortium of private and state-backed investors. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       58],
      "assets/images/resized/0019/0152/190152v1-max-150x150.png"],
     [[250,
       96],
      "assets/images/resized/0019/0152/190152v1-max-250x250.png"],
     [[336,
       130],
      "assets/images/resized/0019/0152/190152v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "J\u00fcrgen",
      "last_name": "Schumacher",
      "permalink": "jrgen-schumacher",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Stefan",
      "last_name": "Fischer",
      "permalink": "stefan-fischer",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u20ac4.3M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.finsmes.com/2012/05/algiax-pharmaceuticals-raises-e4-3m-funding.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Algiax Pharmaceuticals Raises \u20ac4.3M in Funding",
    "raised_amount": 4300000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2012,
    "funded_month": 5,
    "funded_day": 16,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "High-Tech Gruenderfonds",
         "permalink": "high-tech-gruenderfonds",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0002/8109/28109v4-max-150x150.jpg"],
             [[250,
               69],
              "assets/images/resized/0002/8109/28109v4-max-250x250.jpg"],
             [[450,
               125],
              "assets/images/resized/0002/8109/28109v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "KFW",
         "permalink": "kfw-2",
         "image":
          {"available_sizes":
            [[[150,
               87],
              "assets/images/resized/0006/8115/68115v1-max-150x150.png"],
             [[180,
               105],
              "assets/images/resized/0006/8115/68115v1-max-250x250.png"],
             [[180,
               105],
              "assets/images/resized/0006/8115/68115v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Max-Planck-Str. 15a",
    "address2": "",
    "zip_code": "40699 ",
    "city": "Erkrath",
    "state_code": null,
    "country_code": "DEU",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}